REGISTER
LOG IN
HOME
RESOURCES
Publications
Conference Calendar
Past Quiz Results
ARTICLES
First-ever Study of Mycology Lab Practices in Asia
Fereydounia khargensis: A New Opportunistic Yeast Reported from Malaysia
9 Years of MMTN: Improving Fungal Disease Management in Asia Pacific
Echinocandins: Clinicians' Guide
Fungemia blood culture media
Deep dermatophytosis
AFWG Education Module 4: Is Antifungal Susceptibility Testing Useful for Clinical Management?
AFWG Education Module 5: TDM of Antifungal Agents - Essential or Optional?
AFWG Education Module 6: Antifungal Stewardship
Itraconazole: A Quick Guide for Clinicians
Evolving Fungal Landscape in Asia
Laboratory Diagnosis of Pythiosis
ICMR Issues C. auris Advisory
Strengths and Limitations of Imaging for Diagnosis of IFI
Candidemia: Lessons Learned from Asian Studies for Intervention
Pivotal Asian Invasive Mold Study
Mycetoma in Asia: Still veiled in mystery
Cryptococcosis
New Antifungal Agents
Making Precise Diagnoses: Experience from the Laboratory Skills Enhancement Course
AFWG Online Education Module 3: Optimizing Dosing in IFI Management
AFWG Online Education Module 2: Antifungal Prophylaxis in Solid Organ Transplantation
AFWG Education Module 1: The Value of Clinical Mycology Laboratories
Cryptococcosis in HIV and non-HIV infected patients
Human Pythiosis
AFWGOnline Privacy Policy has been Updated
Recent Advances of Fungal Diagnostics in Asian Laboratories
Deep Dermatophytosis: A Case Report
Emerging yeast infections in Asia
Championing Medical Mycology: Thoughts on the AFWG Laboratory Skills Enhancement Course
Mucormycosis and Pythiosis – New Insights
AML and the high risk of multiple infectious complications
Do We Need Modification of Recent IDSA & ECIL Guidelines while Managing Patients in Asia?
A hospital’s experience with candidemia and empirical therapy
Fungal Academy 2015
Fluconazole in 2015
Fungal isolation protocol
Influencing Aspergillus
Fungal Asthma
Aspergillus
Laboratory Diagnosis of IPA
Two-Hot-to-Handle
Voriconazole
Educational Organizations
Literature Updates
 

Articles

Strengths And Limitations Of Imaging For Diagnosis Of IFI

Share this
page



Share
this page

Dr Tan Ban Hock
Senior Consultant
Department of Infectious Diseases
Singapore General Hospital
Singapore

In the most recent iteration of the European Organization for Research and Treatment of Cancer/Mycoses Study Group consensus, the clinical criteria for defining probable lower respiratory tract fungal disease are all radiologic.1 They are based on the presence of 1 or more of the following signs on computed tomography (CT)1:

  • Dense, well-circumscribed lesions(s) with or without a halo sign;
  • Air-crescent sign; or
  • Cavity.

These criteria were developed more for research use rather than usual clinical practice, but they nonetheless provide potentially valuable guidance.

Halo sign

The CT halo sign indicates ground glass attenuation surrounding a pulmonary nodule.2 It is caused by angioinvasion and tissue infarction, with surrounding hemorrhage.

The halo sign is not unique to invasive fungal infections (IFI), and can be caused by other pathologies, such as Wegener’s granulomatosis and Kaposi’s sarcoma.2 However, in an autopsy-based study of neutropenic patients with hematologic malignancy, with or without invasive pulmonary aspergillosis (IPA), the halo sign appeared to be the most specific for IPA: it was evident in 13/17 IPA versus 0/31 non-IPA patients (p<0.0001).3

However, the halo sign is transient and therefore will not be visible on CT in all patients with IPA.4 Thus, early CT is valuable. Furthermore, the halo sign is prognostic: initiation of antifungal treatment based on identification of a halo is associated with significantly improved treatment response and survival.5

Air-crescent and reversed halo sign

In the context of IPA, an air-crescent sign requires no pre-existing cavity, and is caused by parenchymal cavitation.6 It typically occurs about 2 weeks after detection of the initial radiographic abnormality, and often coincides with white blood cell recovery.6

Meanwhile, a reversed halo sign may be an indicator of pulmonary mucormycosis, and detection may allow the early initiation of appropriate therapy. 

Overall, used appropriately and in context, lung CT remains a key pillar of the diagnostic process for IFI, particularly in neutropenic patients.

Highlights of the Medical Mycology Training Network Conference, August 5–6, 2017, Kuala Lumpur, Malaysia.

References

  1. De Pauw B, et al. Clin Infect Dis 2008;46:1813-1821.
  2. Lee YR, et al. Br J Radiol 2005;78:862-865.
  3. Kami M, et al. Mycoses 2002;45:287-294.
  4. Caillot D, et al. J Clin Oncol 2001;19:253-259.
  5. Greene RE, et al. Clin Infect Dis 2007;44:373-379.
  6. Walker CM, et al. AJR Am J Roentgenol 2014;202:479-492.
  7. Legouge C, et al. Clin Infect Dis 2014;58:672-678.
SIGN UP FOR NEWSLETTER
SIGN UP

This field is required. Please enter your email address.
Thank you for signing up for the AFWG newsletter.
You have previously subscribed for AFWG newsletter.